rasagiline has been researched along with Age-Related Memory Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, P; Cheng, X; Cheng, Y; Lu, X; Sang, Z; Shi, J; Wang, K; Yang, J; Zhang, P; Zhang, Q; Zheng, C | 1 |
| Chen, Y; Huang, W; Shohami, E; Weinstock, M | 1 |
| Bejar, C; Finberg, JP; Gross, A; Poltyrev, T; Wang, RH; Weinstock, M; Youdim, MB | 1 |
3 other study(ies) available for rasagiline and Age-Related Memory Disorders
| Article | Year |
|---|---|
Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Biological Transport; Blood-Brain Barrier; Butyrylcholinesterase; Chalcones; Chelating Agents; Cholinesterase Inhibitors; Coordination Complexes; Copper; Drug Design; Female; Humans; Male; Memory Disorders; Mice; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Protein Binding; Scopolamine; Structure-Activity Relationship | 2019 |
Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Head Injuries, Closed; Indans; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Psychomotor Disorders; Psychomotor Performance | 1999 |
TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Brain Injuries; Cholinesterase Inhibitors; Indans; Male; Memory Disorders; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Scopolamine | 2000 |